The significance of tissue-type plasminogen activator for pretransplant assessment of liver graft viability: analysis of effluent from the graft in rats
Authors:
- Mitsuo ShimadaMSMitsuo Shimada
- Taketoshi SuehiroTSTaketoshi Suehiro
- Yuji SoejimaYSYuji Soejima
- Katsuhiko YanagaKYKatsuhiko Yanaga
- Keizo SugimachiKSKeizo Sugimachi
- 1 July 1994
- journal article
- research article
- Published by Frontiers Media SA in Transplant International
- Vol. 7 (4) , 233-236
Abstract
S We studied the significance of tissue-type plasminogen activator (tPA) on the pretransplant assessment of liver graft viability in rats. The liver grafts were excised from the rats and then divided into two groups. Group 1 consisted of grafts preserved for 4 h in chilled, lactated Ringer's solution (4d̀C) and group 2 consisted of grafts preserved for 6 h in the same solution. After preservation, the liver grafts were flushed out through the portal vein using 5 ml of chilled, lactated Ringer's solution (4d̀C). The entire effluent from the hepatic veins was then collected and analyzed for tPA, ammonia, lactate, pyruvate, glutamic oxaloacetic transaminase, and lactate dehydrogenase. The tPA concentration of effluent in group 2 was significantly higher than that in group 1 (0.80±0.23 ng/ml vs 0.42±0.08 ng/ml, P < 0.05). The lactate, pyruvate, and ammonia levels in group 2 were also higher than those in group 1 (134±13 mg/dl vs 120±2 mg/dl, 0.34±0.40 mg/dl vs 0.09±0.01 mg/dl, and 183±79 μ/dl vs 102±40 μ/dl, respectively). However, the discriminative power of tPA was stronger than that of the other parameters. Histological findings revealed a higher number of try-pan blue-stained sinusoidal lining cells that were detached and swollen in group 2. We conclude that the amount of tPA in the effluent flushed from the graft can serve as a sensitive and reliable indicator of cold-preserved liver grafts in rats.Keywords
This publication has 15 references indexed in Scilit:
- Ischemic Injury in Liver Transplantation: Difference in Injury Sites Between Warm and Cold Ischemia in RatsHepatology, 1992
- The use of high dose aprotinin in liver transplantation: The influence on fibrinolysis and blood lossThrombosis Research, 1991
- Inhibition by aprotinin of tPA-mediated fibrinolysis during orthotopic liver transplantationThe Lancet, 1990
- Evaluation of Protocol Before Transplantation and After Reperfusion Biopsies From Human Orthotopic Liver Allografts: Considerations of Preservation and Early Immunological InjuryHepatology, 1990
- EFFECT OF APROTININ ON INTRAOPERATIVE BLEEDING AND FIBRINOLYSIS IN LIVER TRANSPLANTATIONThe Lancet, 1989
- Reperfusion injury to endothelial cells following cold ischemic storage of rat liversHepatology, 1989
- SINUSOIDAL LINING CELL DAMAGETransplantation, 1988
- MARKERS OF ALLOGRAFT VIABILITY IN THE RAT RELATIONSHIP BETWEEN TRANSPLANTATION VIABILITY AND LIVER FUNCTION IN THE ISOLATED PERFUSED LIVERTransplantation, 1987
- Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex.Proceedings of the National Academy of Sciences, 1983
- Fibrinolysis at Rest and after Exercise in Hepatic CirrhosisBritish Journal of Haematology, 1969